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Evidence against increased glomerular pressure initiating diabetic
nephropathy. Studies were carried out to determine whether exagger-
ated glomerular hydraulic pressure (P0) initiates the development of
glomerular pathology and proteinuria in insulin—dependent diabetic
rats. Normotensive (WKY) and hypertensive rats (SHR) were made
diabetic by streptozotocin injection. One group of SHR diabetic rats
was treated with antihypertensive drugs to reduce blood pressure. One
week after onset of diabetes, micropuncture determinations of P0,
measured by stopped—flow technique, revealed that P0 was higher in
WKY diabetics than in non-diabetic WKY controls, and that P0 was
even higher in SHR diabetics (P < 0.05). Similarly prepared groups of
animals were followed for six months, approximately one fifth to one
third of the expected life span of these rats. Tail systolic blood—pressure
measurements documented continuous severe systolic—hypertension in
SHR diabetics, normal pressure in the WKY diabetics and hypotension
in the SHR diabetics treated continuously with antihypertensive drugs.
Urinary protein excretion, measured monthly, was statistically the
same in all groups, with no evidence of a progressive rise in the SHR
diabetics. P0 measured in two rats from each group after four months of
diabetes was similar to values found after one week of diabetes.
Semiquantitative histologic scoring of glomerular mesangial expansion
after six months of diabetes failed to demonstrate any significant
difference between the normotensive WKY diabetics and the hyperten-
sive SHR diabetics. These observations suggest that elevated P0 does
not in itself initiate glomerular pathology or proteinuria in diabetes.
Since the SHR diabetics did not have higher glomerular filtration rates
than the WKY diabetics, the data do not exclude the possibility that
glomerular pathology and proteinuria are causally related to high
plasma flow or filtration rates. Lowering of blood pressure to
hypotensive levels in SHR diabetics afforded protection against the
development of early diabetic glomerulopathy.
It has been proposed that elevated hydraulic pressure and/or
plasma flow rate in the glomerulus of diabetic patients and
animals may be responsible for both initiating and causing
progression of diabetic nephrosclerosis and proteinuria [1—31. In
the early stages of insulin dependent diabetes (IDDM) in man,
as well as in streptozotocin induced diabetes in rats, renal
plasma flow (RPF) and glomerular filtration rate (GFR) are
often significantly higher than normal in the presence of a
normal perfusion pressure [4—10], thus indicating that renovas-
cular resistance (RVR) is reduced. In normotensive diabetic
Received for publication September 24, 1985
and in revised form February 10 and August 18, 1986
© 1987 by the International Society of Nephrology
rats, glomerular capillary hydraulic—pressure (PG) is signifi-
cantly elevated, and afferent and efferent arteriolar resistances
are reduced when measured three to 15 weeks after onset of
diabetes [10]. A number of clinical studies have shown that
when diabetes is complicated by hypertension, the rate of
decline of renal function is accelerated, and when hypertension
is brought under control, the rate of deterioration slows [11—15].
These clinical observations are consistent with the hypothesis
that high pressure in the glomerular capillaries is a major cause
of renal damage in diabetes.
In order to examine this question further, we measured G,
glomerular filtration rate (GFR) and renal plasma flow (RPF) in
spontaneously hypertensive rats (SHR) soon after they were
made diabetic with streptozotocin. Control groups consisted of
normotensive WKY diabetic rats, and SHR diabetic rats treated
with antihypertensive drugs. We then followed similarly pre-
pared groups of rats for six months, evaluating proteinuria,
creatinine clearance and renal histology. We found that in spite
of a significantly higher P6 in the SHR diabetic rats at the
initiation of diabetes, these rats did not develop more protein-
uria or histologic damage than normotensive diabetic rats.
These observations do not support the hypothesis that elevated
glomerular hydraulic pressure initiates diabetic glomerular
damage. The data do not exclude the possibility that high
glomerular blood flow and/or filtration rate may be causally
related to diabetic glomerulopathy. Inducing long term hypo-
tension seemed to afford protection against development of
early diabetic glomerular lesions.
Methods
Initial measurements
Micropuncture studies were carried out on male two to
three—month—old SHR and WKY rats, weighing 225 to 275 g.
Five groups of rats were studied: SHR non-diabetic; WKY
non-diabetic; SHR diabetic; WKY diabetic; and SHR diabetic
treated for hypertension. Diabetes mellitus was produced by
i.v. injection of streptozotocin in citrate buffer (65 mg/kg),
These animals were given 3 U of NPH insulin subcutaneously
each evening in order to moderate the severity of the diabetes.
The animals were given free access to rat pellet diet and
unlimited amounts of drinking water from a large reservoir. All
diabetic rats had polyuria and glycosuria. The micropuncture
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studies in the diabetic rats were carried out five to seven days
after streptozotocin injection. In the group treated for hyper-
tension, a combination of drugs previously demonstrated to
normalize blood pressure in SHR within a few days [16] was
added to the drinking water for two to three days before
micropuncture study: chiorothiazide 1 g/liter: reserpine 1.4
mg/liter: hydralazine 80 mg/liter.
On the morning of micropuncture study, the animals were
anesthetized with mactin, 100 mg/kg, given by i.p. injection.
Surgical preparation of the jugular vein, carotid artery, and left
kidney was as described previously [17]. The animals received
i.v. rat plasma equal to 1% of body weight, followed by a
constant i.v. infusion of Ringer's lactate solution containing
14C-inulin, at a rate of 0.05 mi/mm. Arterial blood samples were
collected at the beginning of the experiment for measurement of
glucose (Beckman glucose analyzer, Beckman Instruments,
Inc., Fullerton, California, USA), BUN (Beckman BUN ana-
lyzer) total protein, pH, pCO2, sodium and potassium by
methods described previously [171. Urine was collected from
the bladder for measurement of '4C-inulin. Blood was collected
from the left renal vein with a small gauge needle for measure-
ment of '4C-inulin extraction [17]. Mean blood pressure was
recorded continuously [17].
Intratubular hydraulic pressure measurements were made in
the earliest accessible convolutions of surface proximal tubules,
identified by pulse i.v. injection of FD and C green dye. The
servo-null technique was used to measure intraluminal pres-
sures [18]. Free flow pressure (FFP) was first measured, and
then the tubule was filled completely with heavy castor oil distal
to the pressure sensing pipet, by means of a second micropi-
pette. The pressure proximal to the oil block rose and reached
a plateau within one to two minutes. This new pressure was
taken as the stopped flow pressure (SFP). Arterial coiloid
oncotic pressure (hA) was calculated from the measured protein
concentration [18]. Glomerular hydraulic pressure was calcu-
lated from the expression:
= SFP + hA. (1)
In other surface proximal tubules, tubular fluid was collected,
its volume measured, and [14C] determined by liquid scintilla-
tion counting. Single nephron glomerular filtration rate
(SNGFR) was calculated by the expression:
SNGFR = TFR x TF/P1 (2)
where TFR is the rate of tubular fluid collected into the pipet
and TF/P1 is the ratio of '4C-inulin in tubular fluid/plasma.
Whole kidney GFR and RPF were claculated from 14C inulin
clearance and extraction measurements, as described previ-
ously [17].
Long term measurements
Four groups of eight rats each were studied simultaneously
for six months: SHR non-diabetic; SHR diabetic; WKY dia-
betic; and SHR diabetic treated for hypertension. The latter
group was given the same combination of antihypertensive
drugs (reserpine, chlorothiazide, and hydralazine) daily in their
drinking water throughout the study. All rats were two to three
months of age at the beginning of study. The methods of
inducing diabetes and treating hypertension were the same as
described above. Animals were weighed monthly. Urine collec-
tions were obtained monthly by housing animals in individual
metabolic cages, for measurement of glucose, total protein, and
creatinine (Beckman creatinine analyzer). Systolic blood pres-
sure was measured monthly in awake animals, using a tail cuff
method [17]. At the end of four months, two rats from each
group were anesthetized and prepared for micropuncture study
as described above. In addition, two WKY rats of the same age
(6 months old) were also studied, although monthly blood
pressure and protein excretion were not measured in these
normal rats. SFP was measured in six to eight proximal tubules
of each animal, and Po was calculated from Equation 1. At the
end of six months, a 24-hour urine collection was obtained from
the six remaining animals of each group for creatinine measure-
ment. Blood was then obtained by cardiac puncture for creati-
nine measurement, and the animal was exsanguinated. The
kidneys were immediately excised, bisected, and two coronal
slices 2 to 3 mm thick were fixed in buffered formalin. Endog-
enous creatinine clearance was calculated from the urine and
blood collected on the day of sacrifice.
Morphology
Three-sm-thick sections of the kidneys were stained with
hematoxylin and eosin, and by the periodic acid Schiff (PAS)
reaction for histologic examination by light microscopy. The
sections were coded and the pathologist (LS) had no knowledge
of the group of animals from which individual kidneys came. A
semiquantitative system was used to grade glomerular mesan-
gial pathology consistent with diabetic changes [19]. In each of
the experimental animals, 50 glomeruli were examined from
comparable portions of the kidney, midway between the two
poles. Each glomerulus was examined for evidence of mesan-
gial expansion, of either the diffuse or segmental type, deter-
mined on PAS stained slides. Each glomerulus was graded 0 to
3+ corresponding to the number of abnormal lobules, in the
case of segmental expansion, or the severity of the abnormality
of the entire glomerulus in the case of diffuse mesangial
expansion. Grade 1+ was applied to glomeruli in which the
amount of PAS positive material was twice that of a normal
(grade 0) glomerulus. The accumulation could be either as
irregular streaks throughout the mesangium (diffuse type) or
localized to a single lobule. A grade 2+ glomerulus had 2
lobules with mesangial expansion, or the diffuse expansion with
PAS positive material was three times that of a normal
glomerulus. A grade 3+ glomerulus had four times as much
PAS positive material in the mesangium, or three or more
lobules with segmental collapse of capillaries. Each section was
scored twice, to ensure reproducibility. The glomerular score
for each kidney was then calculated by summing the individual
scores. After all sections had been interpreted, they were
decoded by another author (DN), assigned to the proper group
of animals, and the mean SEM score for each group was
calculated. At least 300 glomeruli were analyzed in each group
of rats, each glomerulus being scored twice. In the two control
WKY rats, age six months, mesangial expansion of the diffuse
and segmental type was evaluated in 300 glomeruli by the same
methods.
Statistical analysis of micropuncture and clearance data was
made by one way analysis of variance (ANOVA), and Tukey's
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Table 1. Summary of blood chemistries during micropuncture study, five to seven days after streptozotocin
Plasma
Group pH
pCO2
mm Hg
HCO
,nEq/liter
Na
mEqiliter
K
mEqiliter
BUN
mg/d!
glucose
mg/dl
WKY 7.38 43.2 24.0 146 4.2 20.7a 126b.c,d
(7) 0.02 2.7 1.0 2.0 0.2 0.8 7
SHR 7.40 41.8 22.8 142 4.4 28.9e 121,g
(8) 0.02 1.7 0.9 3.0 0.2 1.2 6
WKY-diabetic 7,33h 43.7 23.0 145 4.2 203h 445
(8) 0.02 3.8 2.0 1.6 0.1 1.9 28
SHR diabetic 7.44 38.5 26.2 146 4.4 31.3 416
(7) 0.02 2.7 1.1 1.4 0.1 1.4 33
SHR diabetic + 7.35 44.2 23.4 144 4.4 31.6' 403
antihypertensive Rx 0.03 3.4 1.5 1.1 0.2 2.5 36
(8)
Data presented as mean se, P < 0.05. a WKY vs. SHR b WKY vs. WKY diabetic C WKY vs. SHR diabetic ' WKY vs. SHR diabetic-Rx
SHR vs. WKY diabetic SHR vs. SHR diabetic g SHR vs. SHR diabetic-RX hWKY-diabetic vs. SHR diabetic 'WKY-diabetic vs. SHR
diabetic-Rx
method was used for comparisons of means among the various
groups (20).
Results
Micropuncture data one week and 16 weeks after onset of
diabetes
The blood chemistries measured during micropuncture study
five to seven days after streptozotocin injection are shown in
Table 1. There were no significant differences among the groups
with regard to pCO2, HC03, Nat, or K, and all were within
the normal range. pH was lower in the WKY diabetic rats than
in the SHR diabetics, due to a combination of a slightly lower
HC03, and higher pCO2. Plasma glucose was in the range of
400 to 450 mgldl in the three diabetic groups, with no significant
differences among them. Blood urea nitrogen (BUN) was sig-
nificantly higher in the three SHR groups than in the two WKY
groups. There was no evidence of ketoacidosis in any of the
diabetic rats at the time of micropuncture study.
Whole kidney GFR, RPF and RVR in these same animals are
shown in Table 2. Because of the enlargement of the diabetic
kidney relative to body weight which is known to occur [5, 6,
211, the data have been normalized to ml/minlg kidney weight.
It is evident that RPF and GFR were significantly higher in the
non-diabetic WKY versus the SHR, in agreement with previous
studies [17, 22—24]. Induction of diabetes in the SHR resulted in
a doubling of RPF and GFR associated with a fall in RVR.
Reduction of blood pressure of SHR diabetics to a normal range
lowered GFR significantly, whereas the mean RPF was not
significantly lower than in untreated SHR diabetics. Induction
of diabetes in WKY rats also led to a marked rise in GFR and
RPF. There was no significant difference in RPF between WKY
diabetics and SHR diabetics. GFR was significantly higher in
the WKY diabetics than the SHR diabetics. RVR was much
higher in SHR versus WKY rats. However, when diabetes was
induced in the SHR, RVR fell markedly to a normal level.
Reduction of blood pressure with a combination of drugs did
not change RVR in SHR diabetic animals. Our findings are in
Table 2. Renal plasma flow (RPF) and glomerular filtration rate
(GFR) during micropuncture study, five to seven days after
streptozotocin
Group
RPF
mi/minlg
GFR
mi/minlg
RVR
mm Hg/mi per min/g
WKY 2.58 080a,b 23.2a
(7) 0.42 0.05 5.0
SHR 170d,e 050d,e 477d,a,f
(8) 0.21 0.04 7.1
WKY diabetic 337 33g.h 18.6
(8) 0.79 0.27 4.7
SHR diabetic 3.85 1.00' 22.3
(7) 0.84 0,08 4.8
SHR diabetic + 2.64 0.65 23.3
antihypertensive Rx 0.52 0.07 5.0
(8)
Differences among means (P < 0.05). a WKY vs. SHR b WKY vs.
WKY diabetic WKY vs. SHR diabetic ' SHR vs. WKY diabetic
a SHR vs. SHR diabetic SHR vs. SHR diabetic Rx g WKY diabetic vs.
SHR diabetic h WKY diabetic vs. SHR diabetic Rx SHR diabetic vs.
SHR diabetic Rx
agreement with previous observations that induction of diabe-
tes in rats results in a marked rise in GFR and RPF and a fall in
RVR shortly after the onset of diabetes [8—10].
The micropuncture and blood pressure data under general
anesthesia in the same animals are presented in Table 3. Mean
arterial BP was much higher in the SHR than in the WKY rats.
Induction of diabetes did not alter blood pressure in either the
WKY or SHR. Two days of antihypertensive treatment before
micropuncture study lowered BP in the SHR diabetics to a
normal value. The spectrum of P0 values in the five groups of
animals at the beginning of the six months of observation is
shown in Table 3 and Figure 1. The mean P0 was slightly higher
in SHR versus WKY non-diabetics, but the difference was not
statistically significant. This is in agreement with a recent study
by Dilley, Stier and Arrenshorst (24). Induction of diabetes
resulted in significant increases in PG in both WKY and SHR.
The increase in the WKY rats was approximately 6 mm Hg, and
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Table 3. Micropuncture and blood pressure data
Group BP SFP rA P0 SNGFR
One week after streptozotocin mm Hgl09 mm Hg265b,c,d mm Hg16.0 mm Hg42.5,1 ni/mm315a,b,cWKY
(7) 2 0.3 0.4 0,8 2.2
SHR 159,g 280"' 15.8 43.8e,g 264e,f,g
(8) 4 1.8 0.7 0.9 2.1
WKY diabetic 114" 315" 174" 483" 51.4k
(8) 0.6 0.4 0.8 0.9 2.2
SHR diabetic 168 37.8 14.8 52.6' 50.2'
(7) 3.2 1.0 0.4 1.0 2.0
SHR diabetic + 112 31.1 15.9 47.1 36.3
antihypertensive Rx 3.2 0.8 0.6 1.0 1.9
Four months after streptozotocin
110 27.2 15.0 42.2WKY
(2) 0.2 0.3 0.9
SHR 165 28.3 16.8 45.1
(2) 1.0 0.8 0.8
WKY diabetic 118 32.7 17.7 50.4
(2) 0.4 0.9 1.0
SHR diabetic 169 39.0 15.1 54.1
(2) 1.1 0.3 0.8
SHR diabetic + 110 32.0 16.0 48.0
antihypertensive Rx (2) 0.9 0.9 0.9
Differences among means, P < 0.05. Numbers in parentheses are numbers of animals. a WKY vs. SHR b WKY vs. WKY diabetic WKY vs.
SHR diabetic" WKY vs. SHR diabetic-Rx SHR vs. WKY diabetic SHR vs. SHR diabetics SHR vs. SHR diabetic Rx h WKY diabetic vs. SHR
diabetic ' WKY diabetic vs. SHR diabetic Rx' SHR diabetic vs. SHR diabetic Rx
E
a
a-
54 —
44 —
42 —
40
WKY SHR WKY SHR SHR
diabetic diabetic diabetic +
Anti-HT Rx
Glomerular capillary hydraulic pressure, P
Fig. 1. Mean values of PG in the five groups of rats, five to seven days
after onset of diabetes.
in the SHR it was 9 mm Hg (P < 0.05). PG was significantly
higher in SHR diabetics than in WKY diabetic rats, by about 4
mm Hg. Treatment of hypertension resulted in a significant fall
in PG in the SHR diabetic animals to a value that was similar to
WKY diabetics, but was nevertheless about 5 mm Hg higher
than in non-diabetic WKY rats. The stopped flow method
causes interruption of tubular fluid flow to the distal tubule thus
disrupting the tubuloglomerular feedback response. In normal
rats, this leads to a significant rise in PG and SNGFR [25].
However, in contrast to normal rats, in the SHR, SNGFR
measurements made from the proximal tubule (interruption of
distal flow) are not different than measurements made from the
distal tubule (no interruption of flow) [22]. Thus, the stopped
flow technique probably alters PG less in the SHR than in
normal rats. In addition, Blantz et al [25] found that interruption
of distal flow has less of an effect on SNGFR in hyperglycemia
than in euglycemia. Therefore, the stopped flow method to
evaluate PG in the SHR and diabetic rats of the present study
probably introduced less artifact than it does in normal
hydropenic rats.
SNGFR data on the five groups of rats are shown in Table 3.
SNGFR rose markedly in both WKY and SHR animals that
were made diabetic. Normalization of blood pressure of SHR
diabetics decreased SNGFR significantly.
Also shown in the table are measurements of P0 made in two
rats from each group 16 weeks after the onset of diabetes. As
can be seen, the mean P0 in each group was approximately the
same as found five to seven days after the onset of diabetes.
Long term measurements
The monthly BP and weight data for the four groups of rats
studied six months are shown in Table 4. For every month
except month two, systolic blood pressure was significantly
higher in the SHR diabetics than the WKY diabetics. Systolic
pressure in the SHR diabetics was in the range of 160 to 190 mm
Hg throughout most of the six month period, in contrast to 100
to 138 mm Hg in the WKY diabetic rats. Antihypertensive
therapy lowered BP to levels significantly below the untreated
SHR animals, and to a range significantly lower than the
normotensive WKY-diabetic rats for five of the six months.
52 —
50 —
48 -
46 —
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Table 4. Systolic blood pressure and body weight measurements during six month period
Month 1 2 3 4 5 6
SHR(8) BP
Wt
148a,b,c
7
247a,
5
143
9
292a.b,c
8
158C
8
331a.b,c
8
180a,0
6
350a,b,e
7
l73
3
354a,b,c
9
I75
5
360a,b,c
8
WKY diabetic (8) BP
Wt
121d
6
200
15
130
10
221
16
l38'
8
238
21
5
271
12
1d
5
254
22
115d
7
260
15
SHR diabetic (8) BP
Wt
l9l
12
193
7
157
12
202
12
l86
8
251
19
I67
6
249
23
l6l
7
255
25
170
8
262
23
SHR diabetic + BP 106 127 118 83 89 92
antihypertensive Rx 13 10 8 5 5 6
(8) Wt 176
9
186
13
219
10
229
11
243
13
251
14
Differences among means P < 0.05. a SHR vs. WKY diabetic b SHR vs. SHR diabetic ' SHR vs. SHR diabetic-Rx d WKY diabetic vs. SHR
diabetic WKY diabetic vs. SHR diabetic Rx SHR diabetic vs. SHR diabetic Rx
Table 5. Endogenous creatinine clearance after six months of
diabetes and hypertension
mi/mm/kg
SHR (6) 353k
0.21
WKY diabetic (6) 3.97
0.66
SHR diabetic (6) 356b
0.54
SHR diabetic + 5.60
antihypertensive Rx (6) 0.46
I I I I
2 3 4 5 6
Time, months
Fig. 2. Urinary proteinicreatinine ratios in four groups of rats mea-
sured over a six month period. Differences were not statistically
different for months three through six. Symbols are: (0) SHR; (•) SHR
diabetic; (El) WKY diabetic; (X) SHR diabetic + antihypertension Rx.
Thus, clear cut differences in systolic BP were present among
the various groups throughout the period of observation.
The SHR diabetic rats were significantly smaller than the
non-diabetic SHR throughout the six months of study. All three
diabetic groups were smaller than the non-diabetic SHR, indi-
cating that diabetes interfered with growth of the animals.
However, there was no significant differences between SHR
diabetic and WKY diabetic animals in any month.
The urine protein/creatinine ratios are shown in Figure 2. The
data are expressed as this ratio in order to correct for technical
inaccuracies in 24-hour urine collections. The only significant
difference among the groups was in month 2, when the SHR
excreted significantly more protein than the WKY diabetics.
Throughout the remainder of the study however, protein/cre-
atinine ratios were statistically comparable in all four groups.
There was no evidence of a progressive rise in the SHR diabetic
animals. Because urinary creatinine excretion is related to
muscle mass, it is possible that urine protein/creatinine ratios
might be influenced by differences in body weight. However, as
shown in Table 4, body weight was not significantly different
among the three diabetic groups.
The endogenous creatinine clearances measured at the end of
the study are shown in Table 5. In contrast to the measurements
made at the beginning of the six month study (inulin clearance),
this index of glomerular filtration rate was not significantly
higher in SHR diabetics versus non-diabetic SHR. There was
no significant difference between SHR diabetics and WKY
diabetic rats. Creatinine clearance was significantly higher in
the SHR diabetic rats treated with a combination of three
antihypertensive drugs, as compared with the untreated SHR
diabetics. At the beginning of the study, RPF and GFR tended
to be lower in the group treated with antihypertensive drugs
than in the untreated SHR diabetics. Although absolute values
cannot be compared at the beginning and end of the study
because of the different methods used, and anesthetized versus
awake conditions, the relative values among the groups should
be valid.
The results of histologic scoring for mesangial expansion
evaluated in PAS stained sections are shown in Table 6. The
total number of glomeruli evaluated in each group was at least
300. As can be seen, WKY control rats at age six months had a
1.5
1.0
0.5
0
a
a
C
aa
C.)
C
a
0
0.
aC
P < 0.05 by ANOVA a SHR vs. SHR diabetic Rx b SHRdiabetic vs.
SHR diabetic Rx
'A
 
-
7 
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Table 6. Results of glomerular mesangial expansion scoring
Group Pathology score
WKY 15.0 2.5
SHR 21.8 l.9c
WKY diabetic 27.2 11d
SHR diabetic 25.8 l.7
SHR diabetic +
antihypertensive Rx 16.0 1.7
Data presented as mean SE, P < 0.05. a WKY vs. WKY diabetic
b WKY vs. SHR diabetic C SHR vs. WKY diabetic d WKY diabetic vs.
SHR diabetic Rx C SHR diabetic vs. SHR diabetic Rx
cumulative pathology score in 50 glomeruli/animal of 15 2.5.
The SHR at eight to nine months of age had a slightly higher
score but the difference was not statistically different. The
WKY diabetic rats had significantly more mesangial expansion
(diffuse and segmental) than either the non-diabetic WKY rats
or the SHR, consistent with early changes attributable to
diabetes. Although Sprague—Dawley rats can develop mesan-
gial sclerosis of aging, this usually becomes prominent starting
at age nine to 12 months [261. It seems unlikely therefore that
the difference between the WKY and the WKY diabetic rats
can be attributed to the two to three month difference in age,
although some contribution of aging cannot be entirely ex-
cluded. Of central importance to the present study, the SHR
diabetic rats had a glomerular score of 25.8 1.7, which was
not different from the normotensive WKY-diabetic rats. Thus,
in spite of the systemic hypertension and the higher P0 at one
week and four months in the SHR diabetics, glomerular pathol-
ogy was no worse than in normotensive diabetic rats. Of
additional interest is the fact that antihypertensive therapy was
associated with a decrease in deposition of PAS positive
material. In fact, the glomerular score of 16.0 1.7 was the
same as in the normal WKY rats. Representative glomeruli
from WKY, WKY diabetic and SHR diabetic animals are
shown in Figure 3.
Discussion
It has been proposed that diabetic nephrosclerosis may be
initiated by elevated glomerular pressure in the early stages of
diabetes [1—31. According to this hypothesis, high hydraulic
pressure and/or blood flow rates which occur shortly after the
onset of IDDM damage the glomerulus by direct physical
stresses. Increased filtration rate and hydraulic pressure are
presumed to increase passage of proteins across the basement
membrane, and this increased movement of macromolecules
through the glomerular mesangium may initiate mesangial ex-
pansion and eventually glomerular sclerosis [1]. It is well
established that patients and experimental animals with IDDM
often have RPF and GFR values above normal shortly after the
onset of diabetes [4—10]. P0 and SNGFR have been found to be
significantly increased in diabetic rats three to 15 weeks after
streptozotocin injection [3, 101. Moreover, when diabetic pa-
tients develop hypertension, their renal disease progresses
more rapidly [11—151, perhaps because of higher pressures in
the glomerular capillaries. It is controversial however, whether
the hemodynamic abnormalities of IDDM actually initiate dia-
betic nephrosclerosis, or rather contribute to progression of a
lesion induced by the diabetic state itself [19, 27, 28].
Fig. 3. Representative glomeruli from a WKY control rat, (A) a
normotensive (WKY diabetic (B) and a hypertensive (SHR) diabetic rat
(C) six months after onset of diabetes. (PAS stain, 95 X original
magnification. The scoring of the WKY control glomerulus was 0, the
WKY diabetic shows 3+ of the diffuse type, and the SHR diabetic was
3+ of the segmental (lobular) type.
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The present experiments were carried out to determine
whether exaggerated glomerular pressures would accelerate the
early development of diabetic glomerulopathy and proteinuria.
In order to do this, we studied spontaneously hypertensive rats
(SHR) made diabetic by streptozotocin injection, and compared
them to normotensive (WKY) diabetic rats. The period of
observation of six months was chosen because definite bio-
chemical abnormalities due to diabetes are known to start in the
glomerular basement membrane much earlier than this, that is,
12 days [29], and early histologic abnormalities may start as
early as four months after onset of diabetes [30]. Thus, any
effect of hypertension and a high P0 should have been super-
imposed on the early biochemical and histologic changes of
diabetes.
The results of the micropuncture measurements five to seven
days after streptozotocin injection demonstrated that rats with
hypertension and diabetes mellitus did in fact have higher P0
than normotensive diabetic rats (Table 3, Fig. 1), although
SNGFR was not significantly different between these two
groups (Table 3). In the normotensive WKY diabetic rats, P0
was higher than in non-diabetic WKY rats. As shown in Table
2, RVR fell markedly in SHR diabetics as compared with
non-diabetic SHR. This fall in vascular resistance associated
with the diabetic state, which is known to occur in normoten-
sive diabetic rats [10], presumably allowed a greater degree of
transmission of systemic pressure to the glomerular capillaries.
We measured PG in two rats from each of the five groups at four
months after streptozotocin injection (Table 3), and found
pressures to be essentially the same as at one week after
streptozotocin. Thus, the elevated P0 in the hypertensive and
normotensive diabetic rats was present for at least four months.
Continuous treatment with antihypertensive drugs in SHR
diabetics lowered PG at one week and at four months to a level
comparable to that in the normotensive WKY diabetic rats, but
not to a completely normal value.
In spite of the marked differences in systolic BP among the
groups over the six months of observation (a time period
approximately one fifth of the life span of the WKY and one
third of the expected life span of the SHR), and the differences
in P0 at one week and four months after streptozotocin injec-
tion, no differences in either proteinuria or diabetic mesangial
pathology were found between the WKY diabetic and the SHR
diabetic rats. It should be emphasized that P0 was measured in
separate rats from those used for glomerular pathology exami-
nation, and moreover was measured at only two points in time.
It is possible that P0 may have fallen in the SHR diabetics after
four months, thus negating the earlier difference between these
animals and the WKY diabetics. Hirose et al [31] have sug-
gested that renal vascular resistance increases in the diabetic
rat, leading to a return of the expanded mesangium toward
normal. However, in their study this occurred after six months
of diabetes, a later time than our rats were sacrificed. Never-
theless we cannot be certain that the differences in Po measured
at one week and at four months persisted over the entire six
months of observation. The sample measurements of P0 made
at four months do indicate that the difference extended for at
least this period of time. Thus, with these reservations, we
conclude that exaggerated elevation of P0 (SHR diabetics) did
not accelerate the development of mesangial expansion or
proteinuria in diabetic animals. Moreover, endogenous creati-
nine clearance at the end of six months was not significantly
lower in the SHR diabetics than in WKY diabetics (Table 5),
which is consistent with the absence of accelerated glomerular
pathology in the hypertensive group.
Mauer et a! [30] found that diabetes induced in Goldblatt
hypertensive rats resulted in a significant increase in glomerular
diabetic pathology in the unclipped kidney after four months.
The reason for this apparent difference between their observa-
tions and ours is not certain, but two possibilities can be
considered. First, their normotensive diabetic rats used as
controls also had rather severe mesangial thickening and immu-
noglobulin deposits, suggesting that in their strain of rats
significant diabetic pathology was developing without superim-
posed hypertension. Thus, hypertension may have accelerated
a relatively—advanced diabetic process already begun. Second,
the unclipped kidney in their hypertensive rats may have had a
lower vascular resistance than our SHR diabetic rats, allowing
higher glomerular pressures to develop than in our animals. P0
was not measured in their study. In a more recent study, Cohen
and Rosenmann [32] found in Goldblatt hypertensive—diabetic
rats that glomerulosclerosis did not occur more frequently than
in normotensive diabetic rats over a six month period, in
agreement with our findings. They concluded that elevated Po
was not the initiating factor of glomerulosclerosis, as 30% of
their hypertensive diabetic rats did not develop glomeruloscle-
rosis at all.
It should be noted that SNGFR in the SHR diabetics was not
higher than in the WKY diabetics at the beginning of the study
(Table 3) and endogenous creatinine clearance was comparable
in these two groups at the end of the study (Table 5).In a recent
report by Zatz et al [3], a very high protein diet (50% casein) in
diabetic rats was found to result in marked proteinuria and
glomerular pathology, not found in diabetic rats on lower
protein diets. High protein feeding resulted in a striking rise in
SNGFR and plasma flow, as well as P0. Thus, it is possible that
elevated plasma flow and filtration rates are causally related to
development of diabetic glomerular pathology, perhaps in com-
bination with a rise in P0. Alternatively, it is possible that a very
high protein diet might have an effect on the kidney independent
of its effect on glomerular hemodynamics.
Although glomerular hypertension did not seem to accelerate
the early development of diabetic glomerulopathy, it appeared
that lowering blood pressure to hypotensive levels affords
significant protection. As shown in Table 4, systolic blood
pressure in the SHR diabetic rats treated continuously with
antihypertensive drugs was significantly lower than in normo-
tensive WKY diabetics for five out of the six months of study.
At the end of the study, glomerular lesions were significantly
reduced in the group with hypotensive blood pressure, as
compared with WKY diabetics (Table 6), even though P0 was
higher than in normal control rats (Table 3). The protection of
low blood pressure was complete, as the glomerular score was
not different from that in non-diabetic WKY rats. Zatz Ct al [33]
recently reported that enalapril treatment of diabetic rats, in a
dose which produced hypotension, also provided complete
protection against diabetic glomerular pathology, in agreement
with our findings. Endogenous creatinine clearance was highest
in the group treated with antihypertensive drugs (Table 5).
Further studies are needed to determine the mechanism of the
Glomerular pressure and diabetic renal disease 905
protective effect of drug induced hypotension on the develop-
ment of diabetic renal disease.
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